Bumper Offer - Urjas oil Just @ Rs. 1
Oleanz RT 15 Tablet is a commercial drug that is prescribed in the form of Tablet. Schizophrenia are some of its major therapeutic uses. Other than this, Oleanz RT 15 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Oleanz RT 15 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Oleanz RT 15 Tablet can also lead to other problems, which have been listed below. Such side effects of Oleanz RT 15 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Oleanz RT 15 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Oleanz RT 15 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Oleanz RT 15 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Oleanz RT 15 Tablet in conditions like Tardive Dyskinesia, Depression. The section on Oleanz RT 15 Tablet contraindications lists all such conditions.
Drug reaction of Oleanz RT 15 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Oleanz RT 15 Tablet is not safe while driving, and is not addiction.
Oleanz RT 15 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Oleanz RT 15 Tablet is used -
Moderate
Mild
Is the use of Oleanz RT 15 Tablet safe for pregnant women?
Oleanz RT can have harmful effects in pregnant women. If you experience any discomfort after using Oleanz RT, then discontinue the use and take your doctor's advice.
Is the use of Oleanz RT 15 Tablet safe during breastfeeding?
Oleanz RT may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Oleanz RT 15 Tablet on the Kidneys?
There are no side effects of Oleanz RT on the kidneys.
What is the effect of Oleanz RT 15 Tablet on the Liver?
Oleanz RT has very mild side effects on the liver.
What is the effect of Oleanz RT 15 Tablet on the Heart?
Oleanz RT has very mild side effects on the heart.
Oleanz RT 15 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Oleanz RT 15 Tablet unless your doctor advises you to do so -
Is this Oleanz RT 15 Tablet habit forming or addictive?
Oleanz RT 15 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Oleanz RT 15 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Oleanz RT 15 Tablet only as per medical advice.
Is it able to treat mental disorders?
Oleanz RT 15 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Oleanz RT 15 Tablet
Oleanz RT 15 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Oleanz RT 15 Tablet
Taking Oleanz RT 15 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)